Information Provided By:
Fly News Breaks for July 26, 2017
Jul 26, 2017 | 07:14 EDT
Rodman & Renshaw analyst Raghuram Selvaraju started Veru Healthcare with a Buy rating and $5 price target. The company has "multiples shots on goal" and is targeting "massive markets" with differentiated product profiles, the analyst contends.
News For FHCO From the Last 2 Days
There are no results for your query FHCO